Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

On the Difference Between Designing Children and Raising Them: Ethics and the Use of Educationally Oriented Biotechnology

On the Difference Between Designing Children and Raising Them: Ethics and the Use of... The use of educationally oriented biotechnology has grown drastically in recent decades and is likely to continue to grow. Advances in both the neurosciences and genetics have opened up important areas of application and industry, from psychopharmacology to gene‐chip technologies. This article reviews the current state of educationally oriented biological technologies, eventually focusing on the use of psychiatric drugs with children and adolescents to improve their academic performance. Distinguishing between “good” and “bad” uses of biological technologies is complicated by conflicting theoretical views about human development, the etiology of disability, and the diagnostic categories that structure treatments. To address these issues I introduce a set of ethical concepts, which are based on a biopsychosocial approach to human development. The difference between designing children and raising children marks an ethically salient difference between approaches that focus on only part of the child (e.g., her brain) and approaches that focus on the full biopsychosocial complexity of the developing child in context. This clarifies the importance of the child's right to both autonomy and care. Implications for policy and practice are offered. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Mind, Brain, and Education Wiley

On the Difference Between Designing Children and Raising Them: Ethics and the Use of Educationally Oriented Biotechnology

Stein, Zachary
Mind, Brain, and Education , Volume 4 (2) – Jun 1, 2010
Download PDF
15 pages

Loading next page...
 
/lp/wiley/on-the-difference-between-designing-children-and-raising-them-ethics-NyT5odfKSP
Publisher
Wiley
Copyright
© 2010 the Author. Journal Compilation © 2010 International Mind, Brain, and Education Society and Blackwell Publishing, Inc.
ISSN
1751-2271
eISSN
1751-228X
DOI
10.1111/j.1751-228X.2010.01085.x
Publisher site
See Article on Publisher Site

Abstract

The use of educationally oriented biotechnology has grown drastically in recent decades and is likely to continue to grow. Advances in both the neurosciences and genetics have opened up important areas of application and industry, from psychopharmacology to gene‐chip technologies. This article reviews the current state of educationally oriented biological technologies, eventually focusing on the use of psychiatric drugs with children and adolescents to improve their academic performance. Distinguishing between “good” and “bad” uses of biological technologies is complicated by conflicting theoretical views about human development, the etiology of disability, and the diagnostic categories that structure treatments. To address these issues I introduce a set of ethical concepts, which are based on a biopsychosocial approach to human development. The difference between designing children and raising children marks an ethically salient difference between approaches that focus on only part of the child (e.g., her brain) and approaches that focus on the full biopsychosocial complexity of the developing child in context. This clarifies the importance of the child's right to both autonomy and care. Implications for policy and practice are offered.

Journal

Mind, Brain, and Education – Wiley

Published: Jun 1, 2010

References

  • Psychiatric disorders as social constructions: ADHD as a case in point
    Amaral, Amaral
  • Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children.
    Braun, Braun; Kahn, Kahn; Froehlich, Froehlich; Auinger, Auinger; Lanphear, Lanphear
  • What the multimodal treatment study of children with attention deficit disorder did and did not say about the use of methylphenidate for attention defects
    Carey, Carey
  • The neurobiology of Attention Deficit Disorder
    Chamberland, Chamberland; Robbins, Robbins; Sahakian, Sahakian
  • The need for a new medical model: A challenge to biomedicine
    Engel, Engel
  • A theory of cognitive development: The control and construction of hierarchies of skills
    Fischer, Fischer
  • Mind, brain, and education: Building a scientific groundwork for learning and teaching
    Fischer, Fischer
  • The first candidate gene for dyslexia: Turning the page of a new chapter of research
    Grigorenko, Grigorenko
  • How can genomics inform education?
    Grigorenko, Grigorenko
  • The language game of responsible agency and the problem of free will: How can epistemic dualism be reconciled with ontological monism?
    Habermas, Habermas
  • Externalizing behavior problems and academic underachievement in childhood and adolescence: Causal relationships and underlying mechanisms
    Hinshaw, Hinshaw
  • Can neuroscience be integrated into the DSM‐V?
    Hyman, Hyman
  • Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers
    Jensen, Jensen; Hinshaw, Hinshaw; Swanson, Swanson; Greenhill, Greenhill; Conners, Conners; Arnold, Arnold
  • Meta‐analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)
    Li, Li; Sham, Sham; Owen, Owen; He, He
  • Academic and educational outcomes of children with ADHD
    Loe, Loe; Feldman, Feldman
  • Temperament and attention deficit/hyperactivity disorder: The development of a multiple pathway model
    Nigg, Nigg; Goldsmith, Goldsmith; Sachek, Sachek
  • National trends in the use of psychotropic medications by children
    Olfson, Olfson; Marcus, Marcus; Weissman, Weissman; Jensen, Jensen
  • A coherent introduction to systems philosophy—toward a new paradigm of contemporary thought. Metatheory for dynamic systems: Relational organicism‐contextualism.
    Overton, Overton
  • Understanding the agreements and controversies surrounding childhood psychopharmacology
    Parens, Parens; Johnston, Johnston
  • Facts, values, and attention‐deficit hyperactivity disorder (ADHD): An update on the controversies
    Parens, Parens; Johnston, Johnston
  • Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006
    Pastor, Pastor; Reuben, Reuben
  • The economic impact of attention‐deficit/hyperactivity disorder in children and adolescents
    Pelham, Pelham; Foster, Foster; Robb, Robb
  • Generalist genes: Genetic links between brain, mind, and education
    Plomin, Plomin; Kovas, Kovas; Haworth, Haworth
  • Neuro development: How does the teenage brain work
    Powell, Powell
  • Increased methylphenidate usage for attention deficit disorder in the 1990s
    Safer, Safer; Zito, Zito; Fine, Fine
  • Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD‐10 criteria for hyperkinetic disorder
    Santosh, Santosh; Taylor, Taylor; Swanson, Swanson; Wigal, Wigal; Chuang, Chuang; Davies, Davies
  • Who first suggest the diagnosis of attention‐deficit/hyperactivity disorder?
    Sax, Sax; Kautz, Kautz
  • The global market for ADHD medications
    Scheffler, Scheffler; Hinshaw, Hinshaw; Modrek, Modrek; Levine, Levine
  • Who receives a diagnosis of attention‐deficit/hyperactivity disorder in the United States elementary school population?
    Schneider, Schneider; Eisenberg, Eisenberg
  • Structural brain imaging of attention deficit/hyperactivity disorder
    Seidman, Seidman; Valera, Valera; Makris, Makris
  • From neurons to neighborhoods: Old and new challenges for developmental behavioral pediatrics
    Shonkoff, Shonkoff
  • Clinical implications of ethical concepts: Moral self‐understandings in children taking methylphenidate for ADHD
    Singh, Singh
  • Beyond polemics: The science and ethics of ADHD
    Singh, Singh
  • Biomarkers in psychiatry
    Singh, Singh; Rose, Rose
  • Causal models of attention‐deficit/ hyperactivity disorder: From common simple deficits to multiple developmental pathways
    Sonuga‐Barke, Sonuga‐Barke
  • Etiologic subtypes of attention‐deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis
    Swanson, Swanson; Kinsbourne, Kinsbourne; Nigg, Nigg; Lanphear, Lanphear; Stefanatos, Stefanatos; Volkow, Volkow
  • Attention‐deficit hyperactivity disorder and hyperkinetic disorder
    Swanson, Swanson; Sergeant, Sergeant; Taylor, Taylor; Sonuga‐Barke, Sonuga‐Barke; Jensen, Jensen; Cantwell, Cantwell
  • Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths
    Zito, Zito; Safer, Safer; Zuckerman, Zuckerman; Gardner, Gardner; Soeken, Soeken
  • Psychotropic practice patterns for youth: A 10‐year perspective
    Zito, Zito; Safer, Safer; DosReis, DosReis; Gardner, Gardner; Magder, Magder; Soeken, Soeken
  • Trends in the prescribing of psychotropic medications to preschoolers
    Zito, Zito; Safer, Safer; DosReis, DosReis; Gardner, Gardner; Boles, Boles; Lynch, Lynch
  • Recent child phamacoepidemiological findings
    Zito, Zito; Safer, Safer